A 38-year-old woman is on postoperative day 2 following open cholecystectomy. She is using IV-PCA with morphine (demand dose 1.5 mg, lockout 12 minutes). Over the past 4 hours, she has pressed the button 3 times and reports good pain control (pain score 2/10). However, the nursing staff notes that she is drowsy, her respiratory rate has dropped to 12/min, and her oxygen saturation is 94% on room air. What is the most appropriate immediate intervention?

Explanation

## Management of Opioid-Induced Respiratory Depression in PCA ### Clinical Recognition of Opioid Toxicity This patient exhibits the classic triad of opioid overdose: - **Drowsiness/sedation** (altered mental status) - **Respiratory depression** (RR 12/min; normal is 12–20) - **Hypoxaemia** (SpO₂ 94% on room air) **Key Point:** Respiratory depression is a dose-dependent effect of opioids and occurs on a spectrum. Early recognition and dose reduction prevent progression to severe hypoventilation or apnoea. ### Stepwise Management Algorithm ```mermaid flowchart TD A[Opioid-induced respiratory depression detected]:::outcome A --> B{Severity assessment}:::decision B -->|Mild: RR 10-12, SpO₂ 92-95%, drowsy| C[Reduce opioid dose by 25-50%]:::action B -->|Moderate: RR 8-10, SpO₂ 88-92%, difficult to rouse| D[Reduce dose + supplemental O₂]:::action B -->|Severe: RR <8, SpO₂ <88%, unresponsive| E[Naloxone 0.4 mg IV + aggressive support]:::urgent C --> F[Increase O₂ supplementation]:::action D --> F F --> G[Increase monitoring frequency]:::action G --> H[Reassess in 30 minutes]:::decision H -->|Improved| I[Continue modified PCA]:::outcome H -->|Worsening| E ``` ### Why This Patient Needs Dose Reduction, Not Naloxone | Feature | This Patient | Indication for Naloxone | |---------|--------------|------------------------| | Respiratory rate | 12/min (mild depression) | <8/min (severe) | | SpO₂ | 94% (acceptable with O₂) | <88% despite O₂ | | Consciousness | Drowsy but arousable | Unresponsive/comatose | | Pain control | Adequate (2/10) | Irrelevant if life-threatening | **High-Yield:** Naloxone is reserved for **severe** respiratory depression (RR <8, SpO₂ <88%, unresponsiveness). Using naloxone for mild-to-moderate depression: - Causes acute, severe pain (patient was comfortable) - Risks acute withdrawal and hypertension - Is unnecessary when simple dose reduction and oxygen suffice ### Correct Management Steps 1. **Reduce demand dose** from 1.5 mg to 1 mg (33% reduction) 2. **Increase supplemental oxygen** to maintain SpO₂ >95% (corrects hypoxaemia immediately) 3. **Increase monitoring** to every 15–30 minutes (detects further deterioration) 4. **Reassess in 30 minutes** (confirm improvement before resuming normal monitoring) **Clinical Pearl:** The patient's low button-press frequency (3 times in 4 hours) suggests she is not demanding excessive opioid—the current dose is simply too high for her individual pharmacokinetics. Dose reduction is the solution, not naloxone reversal. ### Why Other Options Are Inappropriate **Option A (Reduce dose + increase lockout):** Increasing lockout interval to 15 minutes is unnecessary and may delay analgesia if pain worsens. The dose reduction alone is sufficient; lockout adjustment is not standard for respiratory depression. **Option D (Continue current settings + monitoring):** Passive observation without dose reduction allows continued opioid accumulation and risks progression to severe respiratory depression. This is unsafe and violates the principle of active management of adverse effects.